Skip to content
healthcare.dev
Get a free key

Members Mark clearlax

NDC 68196-306, Polyethylene Glycol 3350, powder, for solution, from Sam's West Inc.

Product NDC
68196-306
Status
Listed
Labeler
Sam's West Inc
Dosage form
POWDER, FOR SOLUTION
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA090685
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68196-306 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • POLYETHYLENE GLYCOL 335017 g/17g

Pharmacologic classes

Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

Package NDCNDC-11Package
68196-306-07681960306073 BOTTLE in 1 CARTON (68196-306-07) / 510 g in 1 BOTTLE (68196-306-03)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 68196-306 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68196-306 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68196-306. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.